Risedronate Attenuates Podocyte Injury in Phosphate Transporter-Overexpressing Rats

Figure 1

Light microscopy following periodic acid-Schiff staining in the kidney from WT-C, WT-R, TG-C, and TG-R rats at 12 weeks of age. Experimental groups were as follows: wild-type littermates (WT) without risedronate administration (WT-C), WT rats with risedronate administration (WT-R), Pit-1 TG rats with risedronate administration (TG-R), and Pit-1 TG rats without risedronate administration (TG-C). Original magnification: ×400. Bar 50 μm.